# Healthy Adult Male Facial Skin Surface Lipid Pheromone p.o. to Treat Opioid Addiction

> **NCT03394911** · PHASE3 · UNKNOWN · sponsor: **Bubba Nicholson** · enrollment: 500 (estimated)

## Conditions studied

- Opioid Addiction
- Opioid Abuse, Continuous Use
- Opioid Use
- Opioid-Related Disorders
- Paternal Pheromone Deficiency
- Opioid Dependence
- Opioid Abuse
- Opioid-use Disorder
- Opioid Intoxication
- Opioid Abuse, Episodic

## Interventions

- **BIOLOGICAL:** 250mg healthy adult male facial skin surface lipid liquid pheromone

## Key facts

- **NCT ID:** NCT03394911
- **Lead sponsor:** Bubba Nicholson
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-31
- **Primary completion:** 2021-11
- **Final completion:** 2021-11
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2020-10-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03394911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03394911, "Healthy Adult Male Facial Skin Surface Lipid Pheromone p.o. to Treat Opioid Addiction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03394911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*